Cel­lec­tis shifts CAR-T man­u­fac­tur­ing in-house, boosts ef­fi­ca­cy com­pared to third-par­ty CD­MOs: #ASH23 

Last year
Cell/Gene Tx
Manufacturing

ADC man­u­fac­tur­ing will like­ly stay with es­tab­lished CD­MOs due to high bar­ri­er to mar­ket en­try

Last year
Manufacturing

Three big win­ners from Ab­b­Vie's $8.7B Cerev­el deal: A drug­mak­er, a CEO and a SPAC

Last year
People
Deals

Allen In­sti­tute and Chan Zucker­berg Ini­tia­tive launch re­search cen­ter to probe mys­ter­ies of the cell

Last year
R&D

Biden ad­min­is­tra­tion lays foun­da­tion for use of march-in rights as it talks up drug price goals

Last year
Pharma
FDA+

Sanofi CEO Paul Hud­son pitch­es 12 block­busters in a bid to con­vince in­vestors on boost­ing R&D spend

Last year
R&D
Pharma

Ab­b­Vie bets that near­ly $20B in deals can bring it in­to the post-Hu­mi­ra fu­ture

Last year
Deals
Pharma

Lian­Bio re­jects Con­cen­tra bid; Tread­well cuts work­ers; As­traZeneca inks CAR-T deal

Last year
News Briefing

Health tech ex­perts lay out how AI is go­ing to shape health­care in 2024

Last year
Health Tech

NASH drug­mak­er He­p­i­on to seek strate­gic al­ter­na­tives

Last year
People
Pharma

Mer­ck de­tails PhII TIG­IT/PD-1 fail in lung can­cer

Last year
R&D

Up­dat­ed: 89bio prices $150M pub­lic of­fer­ing for PhI­II de­vel­op­ment of NASH drug

Last year
Financing
R&D

Art­bio rais­es $90M as ra­dio­phar­ma field finds its foot­ing

Last year
Financing

Re­gen­eron heads to­ward FDA fil­ing for mul­ti­ple myelo­ma bis­pe­cif­ic, set­ting up show­down with J&J, Pfiz­er: #ASH23

Last year
R&D

Brain cell at­las for Alzheimer's dis­ease is the tar­get of NI­H's new col­lab­o­ra­tion with 10x Ge­nomics

Last year
R&D

Wave makes $100M pub­lic of­fer­ing af­ter dos­ing first sub­jects with GSK-part­nered RNA edit­ing drug

Last year
Financing
R&D

Ab­b­Vie makes sec­ond deal in a week, bet­ting $8.7B in cash on CNS biotech Cerev­el 

Last year
Deals
Pharma

US Patent Tri­al and Ap­peal Board to re­con­sid­er Spruce patents around treat­ment for adren­al dis­or­der

Last year
Pharma
Law

Min­neso­ta dis­trict court halts drug price trans­paren­cy law

Last year
Law

Klick Health's an­nu­al hol­i­day greet­ing plays Se­cret San­ta for its own em­ploy­ees

Last year
Pharma
Marketing

FDA asks for more da­ta from Opti­nose, ex­tends re­view time for nasal spray

Last year
R&D
FDA+

Pfiz­er plans to pull out of BIO, fol­low­ing moves by oth­er large drug­mak­ers to re­duce lob­by­ing foot­print

Last year
Pharma
FDA+

Sy­ros' stock up al­most 30% af­ter pos­i­tive ear­ly PhII da­ta for blood can­cer drug

Last year
R&D

Ten63’s deal with Boehringer; Coya sets up agree­ment with Dr. Red­dy’s; Re­NA­gade’s lay­offs

Last year
News Briefing
First page Previous page 234235236237238239240 Next page Last page
A service from the Financial Times